Get started
Author

Jennifer Cullen

Cardiovascular Toxicities of Androgen Deprivation Therapy
2021 · Azariyas A. Challa, Adam Christopher Calaway, et al. · Current Treatment Options in Oncology · 50
PDF
Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS)
2021 · Kathleen W. Zhang, Melissa A. Reimers, et al. · The Journal of Urology · 34
PDF
Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer
2017 · Kai H. Hammerich, Timothy F. Donahue, et al. · Urologic Oncology Seminars and Original Investigations · 30
Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers
2024 · Gary L Ellison, Kathy J Helzlsouer, et al. · JNCI Monographs · 25
PDF
Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression
2020 · Yuqian Gao, Yi-Ting Wang, et al. · Cancers · 15
PDF
A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy
2020 · Fernando Caumont, Galen Conti, et al. · Urologic Oncology Seminars and Original Investigations · 6
PSA doubling time (PSADT) ≤6 months to identify a subgroup of men with biochemically-recurrent prostate cancer (BRPC) after prostatectomy (RP) at highest risk of distant metastasis (dMET).
2016 · Daniel L. Suzman, Jennifer Cullen, et al. · Journal of Clinical Oncology · 3
Mp15-07 Health-related Quality of Life for Men With Low Risk Prostate Cancer Managed With Active Surveillance Compared to a Cancer-screening Cohort Without Prostate Cancer
2014 · Khanh Pham, Claudio Jeldres, et al. · The Journal of Urology · 3
152 All-cause Mortality Among Military Health Care Beneficiaries With Prostate Cancer Undergoing Active Surveillance
2011 · Jennifer Cullen, Stephen Brassell, et al. · The Journal of Urology · 2
Leveraging the National Cancer Institute’s collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancer
2026 · Shannon M Nugent, Rebecca L Ashare, et al. · JNCI Journal of the National Cancer Institute · 1
Abstract A111: Urine-based gene expression panels with focus on prostate cancer in African Americans
2020 · Indu Kohaar, Sreedatta Banerjee, et al. · Cancer Epidemiology Biomarkers & Prevention · 1
Mp34-03 Do Anterior Tumor Location and Race Predict Biochemical Outcomes for Low Risk Prostate Cancer Patients?
2018 · Justin Mygatt, Jennifer Cullen, et al. · The Journal of Urology · 1
PDF
Abstract A106: Temporal trends in late-stage female breast cancer incidence in Texas, 2004-2023
2026 · Erin Gardner, Ali Rizvi, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract A009: Beyond social vulnerability: Identifying Counties with excess advanced-stage lung cancer burden across the Houston Methodist catchment area
2026 · Khamron Micheals, Monica Hernandez, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract B106: Temporal trends in early-onset gynecologic cancers among demographically diverse Texas Gulf-Coast women
2026 · Jennifer Cullen, Erin Garnder, et al. · Cancer Epidemiology Biomarkers & Prevention
Data from Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
2023 · Joseph R. Sterbis, Chunling Gao, et al.
Supplementary Tables S1-S4 from Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
2023 · Joseph R. Sterbis, Chunling Gao, et al.
Study about Predominance of ERG-Negative High-Grade Prostate Cancers in African American Men
2022 · James Farrell, Gavin Yetter, et al. · Book Publisher International (a part of SCIENCEDOMAIN International)
Abstract 2626: Exquisite specificity ofPMEPA1isoforms in regulation of androgen signaling through AR protein degradation in prostate cancer
2019 · Shashwat Sharad, Natashia Benjamin, et al. · Molecular and Cellular Biology / Genetics
Abstract 2772: Recurrent alterations of the TenascinC in highly aggressive neuroendocrine sub-type of prostate cancer
2019 · Prachi Mishra, Michael Kebish, et al. · Tumor Biology
Abstract B57: Distinct genomic alterations in prostate cancer of African American men
2018 · Albert Dobi, Gyorgy Petrovics, et al. · Cancer Epidemiology Biomarkers & Prevention
Pd20-05 Risk of Men With Intermediate Risk Prostate Cancer Going Onto Definitive Treatment During Active Surveillance; Does a High Psa Predict a Worse Outcome?
2018 · John Burns, Lauren Hurwitz, et al. · The Journal of Urology
PDF
Mp34-02 the Impact of Race and Age in Failure and Progression in Patients Under Active Surveillance for Prostate Cancer. Results From a Large Prospective Database
2018 · Fernando Caumont, Lauren Hurwitz, et al. · The Journal of Urology
PDF
Abstract 226: Verification of prostate cancer genomics biomarker candidates at protein level using PRISM-SRM
2017 · Hui Wang, Yuqian Gao, et al. · Cancer Research
Pd42-10 Nuclear Grade Predicts Prostate Cancer Outcomes Among Radical Prostatectomy Patients
2016 · Daniel Kim, Lauren Hurwitz, et al. · The Journal of Urology
Works count: 31
Citation count: 171
H-index: 6
I10-index: 5
Year
Topic
Type